M. De Lena - Concepedia

Author

M. De Lena

Istituti di Ricovero e Cura a Carattere Scientifico

Also Known As

M De Laurentiis, M De Lena, M de Lena, M. De Lena, M. de Lena, Mario de Lena, Michelino De Laurentiis, Midel Lena

133

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

Istituti di Ricovero e Cura a Carattere Scientifico Istituto Tumori Bari Radiation Oncology Institute Fondazione IRCCS Istituto Nazionale dei Tumori Don Carlo Gnocchi Foundation

About

M. De Lena is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	35	2.1K
2	Health Sciences	7	7	365
3	Natural Sciences	2	2	29
4	Biochemistry	2	2	29
5	Public Health	1	1	19

M. De Lena

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
A phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinum Vito Lorusso, C. F. Pollera, Mauro Antimi, European Journal of Cancer Surgical OncologyUrologyTransitional Cell CarcinomaUrinary TractMedicine	1998	289
Phase I and preliminary phase II evaluation of adriamycin (NSC 123127). G. Bonadonna, S. Monfardini, M. De Lena, PubMed Pharmaceutical ScienceStructural FormulaAntibiotic AdjuvantPharmacotherapyAntimicrobial Chemotherapy	1970	278
Clinical Evaluation of Adriamycin, a New Antitumour Antibiotic Gianni Bonadonna, S. Monfardini, M. De Lena, BMJ OncologyStructural FormulaAntibioticsMedicineAnthracycline Group	1969	218
Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II study M. De Lena, Vito Lorusso, Agnese Latorre, European Journal of Cancer Advanced Ovarian CancerMedicinePharmacologyGynecologyPhase Ii Study	2001	167
Multimodal treatment for locally advanced breast cancer. Result of chemotherapy-radiotherapy versus chemotherapy-surgery. M. De Lena, M. Varini, R Zucali, PubMed Multimodal TreatmentSurgical OncologyBreast OncologyTotal Response RateCombined Modality	1981	155
Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients Angelo Paradiso, G. Simone, S. Petroni, British Journal of Cancer	2000	149
Clinical, radiologic, and histopathologic studies on pulmonary toxicity induced by treatment with bleomycin (NSC-125066). M. De Lena, A Guzzon, S. Monfardini, PubMed Health SciencesCollagen FibersRespiratory ToxicologyPharmacologyPathology	1972	127
Response and survival in advanced breast cancer after two non-cross-resistant combinations. Cristina Brambilla, M. De Lena, Anna Rossi, BMJ Advanced Breast CancerBreast OncologyMedicineCancer ManagementPharmacology	1976	119
Antineoplastic and Immunosuppressive Agents. M. De Lena Tumori Journal Tumor ImmunologyMedicineImmunosuppressive TherapyImmunologyTumor Immunity	1975	105
Inflammatory cancer of the breast: Analysis of 114 cases Federico Bozzetti, Roberto Saccozzi, M. De Lena, Journal of Surgical Oncology	1981	93

Page 1